- Pub. Date:
- Cambridge University Press
Glaxo is the world's second largest pharmaceutical multinational. This study of the company, from its beginnings to 1962, is based on unprecedented and unparalleled archival access to the company records. It gives a detailed account of the global operations of Glaxo, and describes not only the evolution of this international business, but studies its research and development programs, its products, and its marketing and management. It is a story of power, money and drugs, the first comprehensive study of a UK-based drugs company.
|Publisher:||Cambridge University Press|
|Product dimensions:||5.98(w) x 8.98(h) x 1.06(d)|
Table of Contents
List of illustrations; List of tables; Acknowledgements; Introduction; Part I. Merchants and Bonnie Babies: 1. The origins - Joseph Nathan and Co; 2. The Nathans and proprietary foods 1903–1918; 3. Boom and depression for Glaxo and the Nathans; 4. Diversification into pharmaceuticals: Glaxo Laboratories Ltd; 5. Early internationalisation and the growth of overseas markets 1909–1939; Part II. Pharmaceuticals in Britain: 6. Glaxo Laboratories and the hinge of fortune: the Second World War; 7. Pharmaceuticals triumphant 1946–1962; 8. Research and development: a strategy of science?; 9. The development and commercial exploitation of griseofulvin; Part III. Internationalisation of Pharmaceuticals: 10. Glaxo Laboratories and the international development of the pharmaceutical industry; 11. Across the Atlantic: North and South America; 12. The Commonwealth I: India and Pakistan; 13. The Commonwealth II: Australia and New Zealand; 14. The Commonwealth III. South Africa; 15. Glaxo in Europe; 16. Epilogue; Appendix; Notes; Selected bibliography; Index.